Rechercher dans ce blog

Monday, April 5, 2021

Analyzing AMD in research, COVID-19-era practice - Ophthalmology Times

proc.indah.link

Mary Elizabeth Hartnett, MD, FACS, FARVO, and Mark Breazzano, MD, discuss current research being conducted involving AMD and maximizing patient outcomes amid the pandemic.


Mary Elizabeth Hartnett, MD, FACS, FARVO,
a distinguished professor in Ophthalmology and Visual Sciences, University of Utah, as well as director of Pediatric Retina at the John A. Moran Eye Center, and Mark Breazzano, MD, a vitreous and retinal surgeon at the Wilmer Eye Institute, Johns Hopkins University, analyze two areas of age-related macular degeneration (AMD) relevant to today's field:

Dr. Hartnett highlights current research being conducted on the pathophysiology of AMD involving very long chain polyunsaturated fatty acids and new mechanism for fibrosis and neovascular AMD.

Dr. Breazzano discusses how the COVID-19 pandemic has altered how ophthalmologists treat wet AMD, and how physicians can maximize their patient outcomes. 

Listen to more EyePod episodes

The Link Lonk


April 05, 2021 at 06:31PM
https://ift.tt/2PUxmnM

Analyzing AMD in research, COVID-19-era practice - Ophthalmology Times

https://ift.tt/2ZDueh5
AMD

No comments:

Post a Comment

Featured Post

Intel Falls on Latest Server Chip Delay; Rival AMD Gains - Yahoo Finance

proc.indah.link (Bloomberg) -- Intel Corp. fell after saying a new version of its Xeon server chip line will go into production in 2022, r...

Popular Posts